10:11
Mike Biologics: Net profit attributable to the parent in the first half of the year decreased by 83.12% year-on-year.
Jin10 Data reported on July 30 that Mike Biologics announced its operating revenue for the first half of the year was 1.075 billion yuan, a decrease of 15.94% year-on-year; the net profit attributable to shareholders was 34.0425 million yuan, a decrease of 83.12% year-on-year; the net cash flow from operating activities was 162 million yuan, a decrease of 23.93% year-on-year.